The announcement of a securities fraud class action lawsuit against Merck & Co is likely to negatively impact its stock price in the short term as it raises concerns about the company's legal and financial standing. The opportunity for investors to lead the lawsuit suggests significant investor dissatisfaction, which could further pressure the stock.